Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia
Identifieur interne : 000489 ( PascalFrancis/Checkpoint ); précédent : 000488; suivant : 000490Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia
Auteurs : Marjan Jahanshahi [Royaume-Uni] ; Virginie Czernecki [France] ; Mateusz Zurowski [Canada]Source :
- Movement disorders [ 0885-3185 ] ; 2011.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Chirurgie.
English descriptors
- KwdEn :
Abstract
We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.
Affiliations:
- Canada, France, Royaume-Uni
- Angleterre, Grand Londres, Ontario
- Londres, Paris, Toronto
- Université de Toronto
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:11-0356325Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia</title><author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>1 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ></inist:fA14><country>France</country><placeName><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name><affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Department of Psychiatry, Toronto Western Hospital, University of Toronto</s1><s2>Toronto</s2><s3>CAN</s3><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">11-0356325</idno><date when="2011">2011</date><idno type="stanalyst">PASCAL 11-0356325 INIST</idno><idno type="RBID">Pascal:11-0356325</idno><idno type="wicri:Area/PascalFrancis/Corpus">000498</idno><idno type="wicri:Area/PascalFrancis/Curation">002820</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000489</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia</title><author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>1 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ></inist:fA14><country>France</country><placeName><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name><affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Department of Psychiatry, Toronto Western Hospital, University of Toronto</s1><s2>Toronto</s2><s3>CAN</s3><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cognition</term><term>Dystonia</term><term>Nervous system diseases</term><term>Quality of life</term><term>Surgery</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term><term>Pathologie du système nerveux</term><term>Qualité de vie</term><term>Cognition</term><term>Chirurgie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Chirurgie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>26</s2></fA05><fA06><s2>7</s2><s3>SUP</s3></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia</s1></fA08><fA09 i1="01" i2="1" l="ENG"><s1>Deep Brain Stimulation for Dystonia: The State of the Art</s1></fA09><fA11 i1="01" i2="1"><s1>JAHANSHAHI (Marjan)</s1></fA11><fA11 i1="02" i2="1"><s1>CZERNECKI (Virginie)</s1></fA11><fA11 i1="03" i2="1"><s1>ZUROWSKI (Mateusz)</s1></fA11><fA12 i1="01" i2="1"><s1>MORO (Elena)</s1><s9>ed.</s9></fA12><fA12 i1="02" i2="1"><s1>ALBANESE (Alberto)</s1><s9>ed.</s9></fA12><fA12 i1="03" i2="1"><s1>HARIZ (Marwan I.)</s1><s9>ed.</s9></fA12><fA12 i1="04" i2="1"><s1>KRAUSS (Joachim K.)</s1><s9>ed.</s9></fA12><fA12 i1="05" i2="1"><s1>VERHAGEN METMAN (Leo)</s1><s9>ed.</s9></fA12><fA12 i1="06" i2="1"><s1>VIDAILHET (Marie)</s1><s9>ed.</s9></fA12><fA14 i1="01"><s1>UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ></fA14><fA14 i1="03"><s1>Department of Psychiatry, Toronto Western Hospital, University of Toronto</s1><s2>Toronto</s2><s3>CAN</s3><sZ>3 aut.</sZ></fA14><fA15 i1="01"><s1>Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ></fA15><fA15 i1="02"><s1>Istituto Neurologico Carlo Besta and Università Cattolica</s1><s2>Milano</s2><s3>ITA</s3><sZ>2 aut.</sZ></fA15><fA15 i1="03"><s1>Department of Neurological Sciences, Rush University Medical Center</s1><s2>Chicago, Illinois</s2><s3>USA</s3></fA15><fA15 i1="04"><s1>Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225</s1><s2>Paris</s2><s3>FRA</s3><sZ>5 aut.</sZ><sZ>6 aut.</sZ></fA15><fA15 i1="05"><s1>Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>3 aut.</sZ></fA15><fA15 i1="06"><s1>Department of Neurosurgery, Medical University, MHH</s1><s2>Hannover</s2><s3>DEU</s3><sZ>4 aut.</sZ></fA15><fA20><s2>S68-S83</s2></fA20><fA21><s1>2011</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000190458070070</s5></fA43><fA44><s0>0000</s0><s1>© 2011 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>78 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>11-0356325</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B17H</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Dystonie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Dystonia</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Distonía</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Qualité de vie</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Quality of life</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Calidad vida</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Cognition</s0><s5>10</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Cognition</s0><s5>10</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Cognición</s0><s5>10</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Chirurgie</s0><s5>11</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Surgery</s0><s5>11</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Cirugía</s0><s5>11</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Mouvement involontaire</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Involuntary movement</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Movimiento involuntario</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Pathologie du muscle strié</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Striated muscle disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Músculo estriado patología</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Trouble neurologique</s0><s5>41</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Neurological disorder</s0><s5>41</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Trastorno neurológico</s0><s5>41</s5></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0><s5>42</s5></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>42</s5></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>42</s5></fC07><fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0><s5>43</s5></fC07><fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>43</s5></fC07><fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>43</s5></fC07><fN21><s1>241</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>Canada</li><li>France</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Ontario</li></region><settlement><li>Londres</li><li>Paris</li><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name></region></country><country name="France"><noRegion><name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name></noRegion></country><country name="Canada"><region name="Ontario"><name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000489 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000489 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:11-0356325
|texte= Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia
}}
| This area was generated with Dilib version V0.6.23. |  |